futureTEKnow Company Profile

Company

BioXcel Therapeutics

BioXcel Therapeutics is a clinical-stage biopharmaceutical company leveraging AI to discover and develop innovative therapies in neuroscience and immuno-oncology.

Headquarters

New Haven, Connecticut, USA

Year Founded

2017

About Us

BioXcel Therapeutics is a biopharmaceutical company that develops innovative medicines using artificial intelligence. The company focuses on neuroscience and immuno-oncology, employing a drug re-innovation strategy that repurposes existing approved drugs with advanced machine learning techniques. Its lead product, IGALMI, is designed for treating agitation in patients with schizophrenia or bipolar disorders. BioXcel is also advancing treatments for conditions such as Alzheimer’s disease and various cancers, aiming to address significant unmet medical needs in these areas.

Trending Companies

Latest Articles

futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.

© 2026 All Rights Reserved.